secwatch.observer — SEC 8-K summary
======================================

Issuer:     ORTHOPEDIATRICS CORP (KIDS)
CIK:        0001425450
Form:       8-K
Filed at:   2026-01-12T23:59:59+00:00
Accession:  0001425450-26-000003
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

OrthoPediatrics posts record FY2025 revenue $236.1M (+15% YoY); guides FY2026 revenue $262-266M
--------------------------------------------------------------------------------

- Q4 2025 revenue $61.3M (+16% YoY); domestic $48.4M (+13%), international $12.9M (+32%).
- FY2025 free cash flow usage over 50% lower than FY2024; Q4 FCF $6-7M.
- FY2026 revenue guidance $262-266M (11–13% growth); expects ~$25M Adjusted EBITDA.
- Received EUMDR certification for Response Spine and trauma/deformity implants.
- Helped 37,500 children in Q4; nearly 1.3 million since inception.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1425450/000142545026000003/0001425450-26-000003-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1425450/000142545026000003/kids-20260112.htm
  HTML page:      https://secwatch.observer/filing/0001425450-26-000003

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer